Results of preoperative application of micronised purified flavonoid fraction as part of a multimodal analgesic regimen in anorectal surgery: a prospective, randomised, placebo-controlled, double-blind study-Reference-Cited by-同舟云学术

Results of preoperative application of micronised purified flavonoid fraction as part of a multimodal analgesic regimen in anorectal surgery: a prospective, randomised, placebo-controlled, double-blind study

Published:2023-08-02 Issue:2 Volume: Page:19-35
ISSN:2223-2427
Container-title:Surgical practice
language:
Short-container-title:jour

Author:

Garmanova T. N.¹^ORCID,Markaryan D. R.¹^ORCID,Kazachenko E. A.¹^ORCID,Ishchenko R. V.¹^ORCID,Lukyanov A. M.¹^ORCID,Krivonosova D. A.¹^ORCID,Agapov M. A.²^ORCID

Affiliation:

1. Lomonosov Moscow State University

2. Immanuel Kant Baltic Federal University

Abstract

This study aims to assess the efficiency of micronised purified flavonoid fraction (MPFF) administration prior to open haemorrhoidectomy on postoperative pain severity reduction.Methods. The prospective clinical study involved patients with haemorrhoidal disease. Participants were randomly divided into two groups: the first one received 1000 mg of MPFF (Detralex®) 15 days before surgery, seven days after surgery, according to the acute haemorrhoid treatment scheme, and 1000 mg per day until 30 days after surgery; the second one received a placebo. The primary endpoint was the frequency of opioid intake.Results. The study included 182 participants (102 and 82 in the experimental and control group, respectively). Postoperative pain at rest and during defecation was significantly lower in the experimental group on days 6—9 postoperatively (p < 0.05). The use of opioids and other NSAIDs after surgery did not differ between groups. There was no significant difference between groups in side effects frequency and time to return to the usual lifestyle. As for the quality of life, the control group had significantly higher levels of self-care difficulty, anxiety and lingering pain/discomfort, being more likely to suffer from other persistent complaints.Conclusion. The preoperative administration of MPFF as analgesia has demonstrated safety and efficacy, effectively reducing postoperative pain in anorectal surgery while avoiding an increase in side effects. Hence, it is recommended for routine implementation in patient care as an essential component of multimodal analgesia during anorectal surgery.

Publisher

Center of Endourology Endocenter

Subject

General Medicine

Reference31 articles.

1. Riss S, Weiser FA, Schwameis K, Riss T, Mittlböck M, Steiner G, Stift A. The prevalence of hemorrhoids in adults. Int J Colorectal Dis. 2012. Feb 27(2):215—220. https://doi.org/10.1007/s00384-011-1316-3.

2. Mansilha A, Sousa J. Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug Therapy. Int J Mol Sci. 2018. Jun 5;19(6):1669. https://doi.org/10.3390/ijms19061669.

3. Ganz RA. The evaluation and treatment of hemorrhoids: a guide for the gastroenterologist. Clin Gastroenterol Hepatol. 2013. Jun 11(6):593—603. https://doi.org/10.1016/j.cgh.2012.12.020.

4. Amiel M, Barbe R. Etude de l’activité pharmacodynamique de Daflon 500 mg [Study of the pharmacodynamic activity of daflon 500 mg]. Ann Cardiol Angeiol (Paris). 1998. Mar 47(3):185—188 (in Fren.).

5. Tsouderos Y. Venous tone: are the phlebotonic properties predictive of a therapeutic benefit? A comprehensive view of our experience with Daflon 500 mg. Z Kardiol. 1991;80 Suppl 7:95—101.